Updated results confirm that addition of bevacizumab to docetaxel as first-line breast cancer treatment improves survival and response rates.
Alice Goodman, Medical Writer
Advertisement
Articles by Alice Goodman, Medical Writer
Advertisement
Latest Updated Articles
- Update Shows Adding Bevacizumab to Chemotherapy Improves Survival
December 12th 2009
Advertisement
Advertisement
Trending on HCPLive
1
Inhaled Treprostinil Improves IPF Outcomes in Phase 3 TETON-1 Trial
2
Diabetes Technology at a Turning Point: What’s New and What’s Next, With Rachael Sood, NP
3
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
4
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
5